Urge Incontinence Bladder Overactivity Study
NCT00475696
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
300
Enrollment
INDUSTRY
Sponsor class
Conditions
Urinary Incontinence
Interventions
DRUG:
Duloxetine
Sponsor
Eli Lilly and Company